<?xml version="1.0" encoding="UTF-8"?>
<p>The World Health Organization has recommended against routinely administering systemic corticosteroids to patients with COVID‐19.
 <xref rid="mja250577-bib-0018" ref-type="ref">18</xref> Nevertheless, a consensus statement by the Chinese Thoracic Society recommends using corticosteroids, albeit prudently,
 <xref rid="mja250577-bib-0019" ref-type="ref">19</xref> ideally in the context of a randomised controlled trial. To undertake such a trial during an ongoing epidemic is challenging. To facilitate study design, we report the impact of corticosteroid therapy in patients with COVID‐19 according to accumulated observational clinical data.
</p>
